 |
 |
 |
 |
A new US study suggests that regular taking of aspirin is linked to increased survival after a breast cancer diagnosis and also to a lower risk of the disease recurring. However, as this was an observational[...]
Ana Ripoll, Rector of Universitat Autonoma de Barcelona (UAB), and Pedro Barato, President of “Organizacion Interprofesional del Aceite de Oliva Espanol” signed a research agreement to carry out a[...]
Adding 30 minutes of daily physical activity should top your list of New Year’s resolutions for a healthier 2010, says Peter Brubaker, professor of health and exercise science at Wake Forest University.[...]
SAN ANTONIO – Investigators are reporting favorable results in a pilot neoadjuvant trial that tested a combination of lapatinib and nab-paclitaxel (AbraxaneR) for the treatment of HER2+ breast cancer. The findings[...]
Some methods of minimally invasive biopsy for breast cancer are nearly as accurate as surgical biopsy but have much less risk of harms, according to a new report funded by HHS’ Agency for Healthcare Research an[...]
Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive, according to Kimberly Blackwell, M.D., associate professor of med[...]
